|
|
Once a
company has a viable product (one that has shown the potential for benefit
through preclinical pharmacodynamics or proof-of-concept studies and can be
manufactured with reasonable consistency), the next step in development is to
provide evidence in an IND (Investigational New Drug) Application that it is
safe to administer the product to humans for the first time (Phase I clinical
trial). This evidence is gathered from a well-designed program of appropriate
statistically-powered preclinical/nonclinical studies. It is at this IND stage
that the preclinical toxicology studies play perhaps their most important role.
More specifically, the design and planning of an appropriate toxicology program
to support a Phase I clinical trial and the statistical interpretation of the
resulting data in terms of safety requires careful consideration of an entire
array of different factors, including the FDA regulatory process, the relevant
FDA and ICH guidance/points-to-consider documents, general principles related to
the statistical design of an appropriate toxicology program, safety issues
specific to a product class, a scientific evaluation of any risk inherent in a
specific product, risk assessment issues, and differences in regulatory
philosophy between the CBER, CDER and CDRH, and the international agencies.
Walker Downey & Associates prides itself in its product-specific
preclinical concept protocols, statistically-powered and prepared with
justification for the type-B pre-IND meeting with the appropriate
agency. Following concept protocol approval by the agency we, acting as
your Authorized Representative, will solicit bids from our list of
reputable Contract Research Organizations (CRO) and function as the
Study Monitor to assure the satisfactory completion and reporting of all
testing. After “doing the right test right” we will summarize the
testing for your Investigators Brochure (IB), 510(k) or IND (Section 8).
Oftentimes, an evidence-based expert opinion will satisfy the
requirements for some regulatory toxicology, thereby potentially
reducing costs to the client and sparing experimental animals. Since
preclinical testing is a time-consuming process that requires careful
planning and evaluation early on and throughout development, Walker
Downey & Associates makes every effort to promote this formal expert
opinion approach. A summary of our Statistical Services is provided
below. Click on any learn more
for additional discussions.
 |
Walker Downey & Associates will serve as an evidence-based
product safety and development statistical consultancy for your
project team from discovery and proof-of-concept through
clinical testing. We will develop data analysis strategies for
all areas of product development. Our staff has extensive
hands-on experience developing and auditing the statistical
package applied to safety studies and we work closely with
clients to ensure appropriate statistics, protocol consistency
and compliance with Good Laboratory Practice (GLP).
Learn more
|
 |
Data
Mining is often considered to be "a blend of statistics, AI
[artificial intelligence], and data base research", which
until very recently was not commonly recognized as a field of
interest for statisticians. Due to its applied importance,
however, the field is emerging as a rapidly growing and major
area in statistics where important theoretical advances are
being made. Please contact us to see how Walker Downey &
Associates Statistical Services can help your company through
Data Mining.
Learn more |
 |
Reliability theory developed apart from the mainstream of
probability and statistics, and was used primarily as a tool to
help nineteenth century maritime and life insurance companies
compute profitable rates to charge their customers. Even today,
the terms “failure rate” and “hazard rate” are often used
interchangeably. Some of the concepts, terms, and models needed
to describe, estimate and predict reliability include: reparable
systems, non-repairable populations, and life-time distribution
models; reliability or survival function; failure (or hazard)
rate. Contact us to see how we can help with your product
reliability estimation.
Learn more |
 |
The
process of peer review is considered critical to establishing a
reliable body of research and knowledge. Regulatory agents
charged with acting upon a submission can only be expert in a
limited area; thus they welcome and rely to some degree on the
third-party peer-review process to lend additional credibility
to the research. Walker Downey & Associates will facilitate a
peer review of preclinical study reports, or other written
documents by our internal scientists who are experts in the
field. Learn
more |
 |
A
longitudinal study is a correlational research study that
involves repeated observations of the same items over long
periods of time. Longitudinal studies are often used in
preclinical and clinical studies to study trends across the
duration of testing. Walker Downey & Associates can use
longitudinal study design/analysis to maximize the power of the
client’s research investigations.
Learn more |
 |
Bioavailability has an indisputable importance for exposure and
effect assessment. Although a variety of definitions, concepts
and methods has been proposed, the adequate implementation of
bioavailability into risk assessment strategies remains an
important tool among chemists, toxicologists and decision
makers. Walker Downey & Associates applies its expert
Statistical Services to help clients evaluate data collected for
product bioavailability determinations.
Learn more |
 |
Walker Downey & Associates’ in-depth knowledge of statistical
modeling for pharmacokinetics facilitates the client’s
prediction of the absorption, distribution, metabolism and
excretion (ADME) of a compound.
We will examine your own in-house data or we will help to identify
a CRO suitable for your product and protocol requirements. We
will also provide management of the CRO from contract details
through study reporting, or provide peer-review of any study
report that you may have generated.
Learn more |
 |
The science of
statistics Learn more |
|
|
|
|